Skip to main content
block W logo University of Washington
School of Public Health

Sean D. Sullivan

faculty photo
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
Professor, Health Services
Professor, Pharmacy (primary appt.)
Adjunct Professor, Medicine - Allergy and Infectious Dis.


PhD   University of California (Berkeley), 1992   (Health Economics)
MS   University of Texas (Austin), 1986   (Pharmacy)
BS   Oregon State University, 1983   (Pharmacy)

Contact Info


office:   H-375, Health Sciences Building

1959 NE Pacific Street
Seattle, WA 98195-7630

campus box:   357630
voice:   206-685-8153
fax:   206-543-3835


Sean D. Sullivan is Professor and Dean of the University of Washington School of Pharmacy. In addition to his joint appointment as Professor of Health Services, He also holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Kaiser Permanente Washington Health Research Institute.

Dr. Sullivan has authored more than 300 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these writings, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is the past chair of the Academy of Managed Care Pharmacy executive committee on the AMCP Format for Formulary Submissions - the United States evidence-based guidelines for formulary decision-making.

Dr. Sullivan is a member of the Medicare Evidence Development and Coverage Advisory Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, European Journal of Health Economics and Core Evidence. He is a past president of the International Society for Pharmacoeconomics and Outcomes Research.

Technology assessment; medical decision making; economic evaluation of pharmaceuticals, particularly in the areas of respiratory disorders, organ transplantation, HIV/AIDS, mental health and clinical decision making

Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures. Med Care. 2017 Feb;55(2):191-198. doi: 10.1097/MLR.0000000000000630.  PMID: 27579915

Basu A, Sullivan SD. Toward a Hedonic Value Framework in Health Care. Value Health. 2017 Feb;20(2):261-265. doi: 10.1016/j.jval.2016.11.022.  PMID: 28237206

Mathai SC, Minai O, Sullivan SD, Lerner D, Levine D. Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment. Respir Med. 2017 Jan;122 Suppl 1:S23-S27. doi: 10.1016/j.rmed.2016.11.002.  PMID: 27890471

Alfonso-Cristancho R, King WC, Mitchell JE, Ramanathan R, Sullivan SD, Belle SH, Flum DR. Longitudinal Evaluation of Work Status and Productivity After Bariatric Surgery. JAMA. 2016 Oct 18;316(15):1595-1597. doi: 10.1001/jama.2016.12040.  PMID: 27755626

Oster G, Sullivan SD, Dalal MR, Kazemi MR, Rojeski M, Wysham CH, Sung J, Johnstone B, Cali AM, Wei LJ, Traylor L, Anhalt H, Hull M, Van Vleet J, Meneghini LF. Achieve Control: A pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes. Postgrad Med. 2016 Oct 3.  PMID: 27690710

Member, dissertation committee for David Kim
Loss relative to Efficient Diffusion (LED) A novel metric for economic evaluation of medical technology and its application to the evaluation of bariatric surgery